Original articleSecukinumab for moderate-to-severe palmoplantar pustular psoriasis: Results of the 2PRECISE study
Key words
Abbreviations used
Cited by (0)
Funding sources: Novartis sponsored the 2PRECISE study and provided funding for conduct of the study, data analysis, and medical writing assistance for the study's publication.
Disclosure: Dr Mrowietz has received grants/honoraria as an investigator and/or consultant from Abbvie, Almirall, Amgen, Biogen Idec, Boehringer Ingelheim, Celgene, Centocor, Dr Reddy's, Eli Lilly and Company, Foamix, Formycon, Forward Pharma, Janssen, Leo Pharma, Medac, MSD, Miltenyi Biotech, Novartis, VBL, and Xenoport. Dr Bachelez has received honoraria as a speaker and advisor from Abbvie, Amgen, Boehringer-Ingelheim, Celgene, Janssen, Leo Pharma, Eli Lilly and Company, Novartis, Pfizer, Sun Pharma, and UCB, and he has received research funding from Pfizer. Dr Burden has received research funding and honoraria from Abbvie, Almirall, Boehringer Ingelheim, Celgene, Janssen, Leo Pharma, Novartis, and UCB. Dr Rissler, Dr Sieder, Dr Orsenigo, and Dr Chaouche-Teyara are employees of Novartis.